Skip to main content
Clinical Trials/CTRI/2024/04/065672
CTRI/2024/04/065672
Not yet recruiting
Phase 3

A Randomized Placebo Control trial to assess effectiveness of homoeopathic medicine Lecithinum 6X in increasing the hemoglobin levels in Anemia in Adolescents. - NI

Dr Harshita Mahawar0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Harshita Mahawar
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Harshita Mahawar

Eligibility Criteria

Inclusion Criteria

  • adolescent patients having haemoglobin levels\-
  • for males less than 12\.5g/dl and more than or equal to 8\.5g/dl
  • for females less than 11\.5g/dl and more than or equal to 8\.5g/dl

Exclusion Criteria

  • patients having chronic diseases, systemic diseases, genetic diseases(sickle cell anemia, thalassemia,etc.).cases with serious complications, psychiatric diseases, pregnant and lactating women, malignancy cases, and immune\-compromised cases. patients under any medications.

Outcomes

Primary Outcomes

Not specified

Similar Trials